Hardwin O’Dowd

743 total citations
19 papers, 467 citations indexed

About

Hardwin O’Dowd is a scholar working on Organic Chemistry, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Hardwin O’Dowd has authored 19 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Molecular Biology. Recurrent topics in Hardwin O’Dowd's work include Malaria Research and Control (7 papers), Synthesis and Catalytic Reactions (5 papers) and Computational Drug Discovery Methods (3 papers). Hardwin O’Dowd is often cited by papers focused on Malaria Research and Control (7 papers), Synthesis and Catalytic Reactions (5 papers) and Computational Drug Discovery Methods (3 papers). Hardwin O’Dowd collaborates with scholars based in United States and China. Hardwin O’Dowd's co-authors include Gary H. Posner, Theresa A. Shapiro, Suji Xie, Poonsakdi Ploypradith, Mikhail Krasavin, Jared N. Cumming, Thomas W. Kensler, Michael H. Parker, Patrick Dolan and Charlotte Wu and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Hardwin O’Dowd

19 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hardwin O’Dowd United States 13 277 167 151 97 65 19 467
Christine Latour France 17 331 1.2× 289 1.7× 152 1.0× 88 0.9× 59 0.9× 23 747
R. Matthew Cross United States 10 219 0.8× 144 0.9× 136 0.9× 47 0.5× 43 0.7× 16 412
I. Kanepe Latvia 14 403 1.5× 75 0.4× 188 1.2× 80 0.8× 62 1.0× 45 644
Elizabeth Hamelink Sweden 14 180 0.6× 203 1.2× 227 1.5× 195 2.0× 70 1.1× 16 508
Richard M. Beteck South Africa 13 319 1.2× 132 0.8× 252 1.7× 70 0.7× 95 1.5× 49 616
Setshaba D. Khanye South Africa 16 474 1.7× 88 0.5× 207 1.4× 53 0.5× 60 0.9× 45 656
Jérôme Cazelles France 10 253 0.9× 480 2.9× 165 1.1× 207 2.1× 79 1.2× 10 676
Miriam Lopez-Sanchez United States 6 200 0.7× 261 1.6× 212 1.4× 106 1.1× 75 1.2× 7 584
Moni Sharma India 14 647 2.3× 172 1.0× 233 1.5× 80 0.8× 95 1.5× 18 825
Jaime Pérez‐Villanueva Mexico 15 271 1.0× 63 0.4× 250 1.7× 219 2.3× 44 0.7× 36 638

Countries citing papers authored by Hardwin O’Dowd

Since Specialization
Citations

This map shows the geographic impact of Hardwin O’Dowd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hardwin O’Dowd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hardwin O’Dowd more than expected).

Fields of papers citing papers by Hardwin O’Dowd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hardwin O’Dowd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hardwin O’Dowd. The network helps show where Hardwin O’Dowd may publish in the future.

Co-authorship network of co-authors of Hardwin O’Dowd

This figure shows the co-authorship network connecting the top 25 collaborators of Hardwin O’Dowd. A scholar is included among the top collaborators of Hardwin O’Dowd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hardwin O’Dowd. Hardwin O’Dowd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
O’Dowd, Hardwin, et al.. (2022). Ketoreductase-Catalyzed Access to Axially Chiral 2,6-Disubstituted Spiro[3.3]heptane Derivatives. Organic Letters. 24(18). 3431–3434. 9 indexed citations
2.
Collier, Philip N., et al.. (2018). Synthesis of a 6-Aza-Isoindolinone-Based Inhibitor of Phosphoinositide 3-Kinase γ via Ruthenium-Catalyzed [2 + 2 + 2] Cyclotrimerization. ACS Medicinal Chemistry Letters. 10(1). 117–120. 8 indexed citations
3.
O’Dowd, Hardwin, Dean Shannon, Vaishali Dixit, et al.. (2015). Discovery and Characterization of a Water-Soluble Prodrug of a Dual Inhibitor of Bacterial DNA Gyrase and Topoisomerase IV. ACS Medicinal Chemistry Letters. 6(7). 822–826. 19 indexed citations
4.
Wang, Tiansheng, Wenxin Gu, Hardwin O’Dowd, et al.. (2012). Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part 2: 4-Amino-pyrido[2,3-d]pyrimidin-5(8H)-ones. Bioorganic & Medicinal Chemistry Letters. 22(11). 3699–3703. 13 indexed citations
5.
Wishka, Donn G., Katherine E. Brighty, Kathleen A. Farley, et al.. (2011). An Asymmetric Synthesis of (2S,5S)-5-Substituted Azepane-2-Carboxylate Derivatives. The Journal of Organic Chemistry. 76(6). 1937–1940. 14 indexed citations
6.
O’Dowd, Hardwin, Jason G. Lewis, Joaquim Trias, et al.. (2008). Novel antibacterial azetidine lincosamides. Bioorganic & Medicinal Chemistry Letters. 18(8). 2645–2648. 25 indexed citations
7.
O’Dowd, Hardwin, Jason G. Lewis, & M. F. GORDEEV. (2008). Novel 6-position modified 1-thioalkyl-lincosamines. Tetrahedron Letters. 49(18). 2979–2981. 3 indexed citations
8.
O’Dowd, Hardwin, Peter S. Margolis, Wen Wang, et al.. (2007). Preparation of tetra-Boc-protected polymyxin B nonapeptide. Tetrahedron Letters. 48(11). 2003–2005. 20 indexed citations
9.
O’Dowd, Hardwin, et al.. (2006). Enantioselective Synthesis of N1999A2. Journal of the American Chemical Society. 128(46). 14825–14827. 29 indexed citations
10.
Raju, B. China, Sampath‐Kumar Anandan, Shihai Gu, et al.. (2004). Conformationally restricted analogs of deoxynegamycin. Bioorganic & Medicinal Chemistry Letters. 14(12). 3103–3107. 17 indexed citations
11.
Raju, B. China, Kathleen H. Mortell, Sampath‐Kumar Anandan, et al.. (2003). N- and C-terminal modifications of negamycin. Bioorganic & Medicinal Chemistry Letters. 13(14). 2413–2418. 42 indexed citations
12.
Posner, Gary H., John P. Maxwell, Hardwin O’Dowd, et al.. (2000). Antimalarial sulfide, sulfone, and sulfonamide trioxanes. Bioorganic & Medicinal Chemistry. 8(6). 1361–1370. 31 indexed citations
13.
Wu, Y. K., Yulin Wu, Fei Shan, et al.. (1999). Recent major advances in the studies on Qinghaosu and related antimalarial agents. 12(9). 687–694. 3 indexed citations
14.
O’Dowd, Hardwin, Poonsakdi Ploypradith, Suji Xie, Theresa A. Shapiro, & Gary H. Posner. (1999). ChemInform Abstract: Antimalarial Artemisinin Analogues. Synthesis via Chemoselective C—C Bond Formation and Preliminary Biological Evaluation.. ChemInform. 30(31). 1 indexed citations
15.
Posner, Gary H., Poonsakdi Ploypradith, Michael H. Parker, et al.. (1999). Antimalarial, Antiproliferative, and Antitumor Activities of Artemisinin-Derived, Chemically Robust, Trioxane Dimers. Journal of Medicinal Chemistry. 42(21). 4275–4280. 109 indexed citations
16.
O’Dowd, Hardwin, Poonsakdi Ploypradith, Suji Xie, Theresa A. Shapiro, & Gary H. Posner. (1999). Antimalarial artemisinin analogs. Synthesis via chemoselective CC bond formation and preliminary biological evaluation. Tetrahedron. 55(12). 3625–3636. 29 indexed citations
17.
Posner, Gary H., Hardwin O’Dowd, Thomas R. Caferro, et al.. (1998). Antimalarial sulfone trioxanes. Tetrahedron Letters. 39(16). 2273–2276. 41 indexed citations
18.
Posner, Gary H., Hardwin O’Dowd, Poonsakdi Ploypradith, et al.. (1998). Antimalarial Cyclic Peroxy Ketals. Journal of Medicinal Chemistry. 41(12). 2164–2167. 44 indexed citations
19.
Posner, Gary H. & Hardwin O’Dowd. (1998). An Antimalarially Active Cyclic Peroxy Ketal. Heterocycles. 47(2). 643–643. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026